Steven A. Shallcross - CEO and CFO, Director at Theriva Biologics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and CFO, Director
Issuer Symbol
TOVX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Steven A. Shallcross since 03 Feb 2025

Holdings reported by Steven A. Shallcross for Theriva Biologics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (right to buy) 475,000 05 Jan 2026 Direct Common Stock

Transactions reported by Steven A. Shallcross for Theriva Biologics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.